Stocks and Investing
Stocks and Investing
Thu, February 29, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, February 28, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Francois Brisebois Reiterated (TARS) at Buy with Increased Target to $59 on, Feb 28th, 2024
Francois Brisebois of Oppenheimer, Reiterated "Tarsus Pharmaceuticals, Inc." (TARS) at Buy with Increased Target from $55 to $59 on, Feb 28th, 2024.
Francois has made no other calls on TARS in the last 4 months.
There is 1 other peer that has a rating on TARS. Out of the 1 peers that are also analyzing TARS, all agrees with Francois's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrea Tan of "Goldman Sachs" Initiated at Hold and Held Target at $19 on, Monday, November 20th, 2023
Contributing Sources